ETON
NASDAQ · Pharmaceuticals
Eton Pharmaceuticals Inc
$56.46
+9.31 (+19.75%)
Open$58.59
Previous Close$47.15
Day High$58.59
Day Low$51.82
52W High$66.37
52W Low$14.27
Volume—
Avg Volume408.5K
Market Cap1.63B
P/E Ratio128.50
EPS$0.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
-78.9% upside
Current
$56.46
$56.46
Target
$11.93
$11.93
$8.04
$11.93 avg
$13.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 85.80M | 55.17M | 122.17M |
| Net Income | -4,937,926 | -2,857,412 | 16.25M |
| Profit Margin | -5.8% | -5.5% | 13.3% |
| EBITDA | 3.43M | 2.10M | 25.36M |
| Free Cash Flow | — | — | 11.15M |
| Rev Growth | +55.5% | +55.5% | -8.5% |
| Debt/Equity | 1.17 | 1.17 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |